Detalles de la búsqueda
1.
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.
Br J Cancer
; 130(1): 63-72, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37973956
2.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931632
3.
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer.
Clin Chem
; 69(1): 23-40, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36322450
4.
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.
Int J Mol Sci
; 24(6)2023 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36982592
5.
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study.
Cancer Immunol Immunother
; 71(12): 3093-3097, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35616698
6.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280658
7.
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.
Clin Chem
; 67(11): 1503-1512, 2021 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34355741
8.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 377(20): 1919-1929, 2017 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28885881
9.
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial.
Eur Respir J
; 56(2)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444410
10.
Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions database.
Ann Rheum Dis
; 81(2): e32, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066555
11.
Self-reported physical activity in smoking pre-cessation is not a protective factor against relapse for all.
Am J Addict
; 24(2): 153-159, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25864604
12.
Barriers to, and Facilitators of Physical Activity in Patients Receiving Chemotherapy for Lung Cancer: An exploratory study.
J Palliat Care
; 31(2): 89-96, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26201210
13.
Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial.
J Dual Diagn
; 11(3-4): 205-16, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26683252
14.
Smoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis.
Eur Arch Psychiatry Clin Neurosci
; 264(5): 379-89, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24619241
15.
Feasibility and Efficacy of an Addiction Treatment Program in Patients With Upper Aerodigestive Tract Cancer.
Subst Use Misuse
; 49(1-2): 103-109, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23919435
16.
Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
J Neurosurg
; : 1-11, 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241682
17.
Neuropsychological assessment fails to predict relapse among cigarette smokers: A prospective study of neurocognitive abilities.
Addict Behav
; 151: 107940, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38134598
18.
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473356
19.
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial.
J Thorac Oncol
; 19(6): 941-953, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159809
20.
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
J Clin Oncol
; : JCO2302166, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552197